Table 2.
Compound | Heterologous host | No. of articles | Yr of first report |
---|---|---|---|
Paclitaxel (taxadiene) | E. coli | 11 | 2001 |
S. cerevisiae | 9 | 2006 | |
Artemisinin (amorphadiene) | E. coli | 24 | 2003 |
S. cerevisiae | 18 | 2006 | |
Carotenoid (lycopene) | E. coli | 158 | 1986 |
S. cerevisiae | 9 | 1994 | |
Carotenoid (zeaxanthin) | E. coli | 64 | 1990 |
S. cerevisiae | 2 | 2009 | |
Carotenoid (astaxanthin) | E. coli | 35 | 1995 |
S. cerevisiae | 4 | 2009 |
Results of a search conducted (26 October 2011) using the PubMed database with either “coli” or “cerevisiae” in conjunction with the molecules in parentheses. The numbers include both primary research and review articles and may include articles not directly related to heterologous biosynthesis. However, the results illustrate the differences in compound-specific host choice and the associated volume of research since heterologous biosynthesis was initiated.